U.S., Feb. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07426068) titled 'Clinical Safety Evaluation and Preliminary Efficacy Study of Subcutaneous Myografts Transplantation' on Feb. 08.
Brief Summary: This study aims to apply autologous differentiated myocyte subcutaneous transplantation in patients with muscle atrophy to explore its safety, feasibility, and efficacy.
Study Start Date: July 01, 2026
Study Type: INTERVENTIONAL
Condition:
Metabolic Disease
Amyotrophy
Intervention:
BIOLOGICAL: Autologous differentiated myocyte transplantation
Autologous differentiated myocytes will be prepared from each participant and transplanted subcutaneously. All enrolled participants will receive the same inter...